Galen announces profits up 52% in Q4
Belfast-based pharmaceutical holding company Galen, has announced product revenues of $140.9m (€110.32m) and operating profits up 52% to $72.9m (€57.07m) for the first quarter to December 31, 2003.
Galen's largest segment is women's healthcare consisting of oestrogen replacement therapies, contraceptives, and prenatal vitamin supplements
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





